Existing Traffic Analysis Clause Samples

Existing Traffic Analysis. The Consultant will analyze and document the operational performance measures of the existing transportation corridor(s) as agreed upon in the analysis methodology.
View Source
Existing Traffic Analysis. Consultant shall prepare and submit to City and WOCPM Existing Traffic Analysis for all traffic count intersections identified in subtask 5.1 and shall include the Draft TSP analysis of the intersections of East Main/▇▇▇▇▇▇, OR66/▇▇▇▇▇▇, and OR66/▇▇▇▇▇▇ Creek Road in order to judge impacts on the surrounding system. Analysis must include deficiencies (e.g. failure to meet application state or local policies or laws). Operational analysis for all facilities, regardless of jurisdiction, must include: Volume-to-capacity ratio Level of Service Multi-Modal Level of Service, utilizing the methodology in the current City TSP Update 95th Percentile queuing Turning movements Non-automobile transportation analysis must include: Volume Type Direction For non-automobile devices that typically require safety equipment (e.g. bicycle, skateboard), the percentage of users wearing safety equipment (at least helmets). Consultant shall obtain approval of methodology and assumptions for the existing conditions, (and for future conditions and alternatives) from TPAU and Region 3 Traffic Office prior to beginning analysis of existing conditions. Consultant shall prepare a Methodology and Assumptions Memorandum for review by TPAU and Region 3 traffic. Methodology and Assumptions Memorandum must cover analysis methodologies and assumptions for developing 30th highest hour volumes, 2034 future baseline volumes (to be developed from forecasts in the City’s Draft TSP Update), and 2034 volumes for any alternatives, travel demand model scenario descriptions, and any other relevant analysis methodologies/assumptions/major parameters used throughout the analysis tasks. Consultant shall obtain three to five years of crash data from Agency’s Crash Data & Reporting Unit for Project Area intersections and adjacent roadway segments. Consultant shall calculate segment and intersection crash rates in the Project Area. Intersection crash rate calculations must use the Highway Safety Manual Critical Rate method. Segment crash rates must be compared with Table II in the Agency’s published Crash Rate Tables for similar facilities. For any identified locations that exceed the published segment or calculated critical intersection rate, Consultant shall identify and present crash patterns and potential countermeasures/safety improvements in the Existing Traffic Analysis. Consultant shall document summary crash data results including crash rates in Existing Traffic Analysis. All traffic volumes must u...
View Source

Related to Existing Traffic Analysis

  • Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • Technology Research Analyst Job# 1810 General Characteristics

  • Investment Analysis and Implementation In carrying out its obligations under Section 1 hereof, the Advisor shall: (a) supervise all aspects of the operations of the Funds; (b) obtain and evaluate pertinent information about significant developments and economic, statistical and financial data, domestic, foreign or otherwise, whether affecting the economy generally or the Funds, and whether concerning the individual issuers whose securities are included in the assets of the Funds or the activities in which such issuers engage, or with respect to securities which the Advisor considers desirable for inclusion in the Funds' assets; (c) determine which issuers and securities shall be represented in the Funds' investment portfolios and regularly report thereon to the Board of Trustees; (d) formulate and implement continuing programs for the purchases and sales of the securities of such issuers and regularly report thereon to the Board of Trustees; and (e) take, on behalf of the Trust and the Funds, all actions which appear to the Trust and the Funds necessary to carry into effect such purchase and sale programs and supervisory functions as aforesaid, including but not limited to the placing of orders for the purchase and sale of securities for the Funds.

  • Information Technology Accessibility Standards Any information technology related products or services purchased, used or maintained through this Grant must be compatible with the principles and goals contained in the Electronic and Information Technology Accessibility Standards adopted by the Architectural and Transportation Barriers Compliance Board under Section 508 of the federal Rehabilitation Act of 1973 (29 U.S.C. §794d), as amended. The federal Electronic and Information Technology Accessibility Standards can be found at: ▇▇▇▇://▇▇▇.▇▇▇▇▇▇-▇▇▇▇▇.▇▇▇/508.htm.